marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 23.10.2024
Viking Therapeutics Gewinn / Verlust 2011-2024 | VKTX
Gewinn / Verlust Jährlich Viking Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
2.3 B | 1.88 B | 355 M | 531 M | 453 M | 480 M | 135 M | 22.5 M | 13.2 M | - | - | - | - |
Anteile |
94.3 M | 76.8 M | 77.2 M | 72.6 M | 72 M | 57.6 M | 26 M | 16.3 M | 6.36 M | - | - | - | - |
Kurshistorie |
24.4 | 24.4 | 4.6 | 5.63 | 8.02 | 7.65 | 4.06 | 1.19 | 3.41 | - | - | - | - |
Nettogewinn |
-85.9 M | -68.9 M | -55 M | -39.5 K | -25.8 M | -22.1 M | -20.6 M | -14.7 M | -23.4 M | -21.9 M | -146 K | - | - |
Umsatz |
- | - | - | 10.7 K | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | 10.7 K | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-101 M | -70.4 M | -55.7 M | -42.7 M | -32.7 M | -26.2 M | -19.1 M | -13.8 M | -12 M | -23.5 M | - | - | - |
Zinsaufwendungen |
14.9 M | 1.49 M | 692 K | 3.17 M | 6.91 M | 4.1 M | -1.51 M | -885 K | -11.4 M | 1.58 M | - | - | - |
EBITDA |
-101 M | -70.4 M | -55.7 M | -38.9 K | -32.4 M | -21.6 M | -19.3 M | -12.9 M | -22.4 M | -21.3 M | -122 K | - | - |
Betriebsaufwand |
101 M | 70.4 M | 55.7 M | 42.7 K | 32.7 M | 26.2 M | 19.1 M | 13.8 M | 12 M | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
37 M | 16.1 M | 10.7 M | 10.7 M | 9.13 M | 7.12 M | 5.33 M | 4.85 M | 5.03 M | 1.24 M | 89.5 K | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Viking Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
111 M | 110 M | 100 M | 99.8 M | 99 M | 78.4 M | 78.3 M | 76.5 M | 76.8 M | 77.4 M | 78.2 M | 78 M | 77.9 M | 74.8 M | 73.2 M | 72.6 M | 72.5 M | 72.4 M | 72.4 M | 72 M | 71.9 M | 71.8 M | 71.7 M | 61.2 M | 52.8 M | 44.6 M | 35.8 M | 27.5 M | 24.1 M | 22.4 M | 20.8 M | 19 M | 17.1 M | 9.02 M | 9.68 M | 8.95 M | 7.33 M | 4.07 M | 6 M | 4.52 M | 4.22 M | 2.76 M | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-24.9 M | -22.2 M | - | -22.5 M | -19.2 M | -19.5 M | - | -15.8 M | -17.4 M | -16.1 M | - | -13.2 M | -15.4 M | -14 M | - | -9.29 M | -9.57 M | -9.69 M | - | -5.73 M | -7.67 M | -4.92 M | - | -6.6 M | -6.67 M | -3.55 M | - | -6.1 M | -5.17 M | -5.22 M | - | -3.81 M | -3.69 M | -3.59 M | - | -4.74 M | -7.87 M | -5.71 M | - | -262 K | -22.8 M | -229 K | - | - | - | - | - | - | - | - | - | - | - | - |
Einnahmen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-36.6 M | -34.1 M | - | -27.3 M | -23.7 M | -20.5 M | - | -16.2 M | -17.6 M | -16.2 M | - | -13.4 M | -15.5 M | -14.2 M | - | -9.84 M | -10.6 M | -10.9 M | - | -7.44 M | -9.57 M | -6.81 M | - | -7.39 M | -6.92 M | -4.8 M | - | -4.69 M | -4.98 M | -4.97 M | - | -3.26 M | -3.58 M | -3.27 M | - | -4.29 M | -2.63 M | -461 K | - | -1.15 M | -21.8 M | -210 K | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
11.6 M | 11.8 M | - | 4.73 M | 4.52 M | 1.01 M | - | 423 K | 199 K | 142 K | - | 160 K | 160 K | 218 K | - | 555 K | 1.03 M | 1.26 M | - | 1.71 M | 1.9 M | 1.88 M | - | 794 K | 253 K | 24 K | - | -1.41 M | -189 K | -253 K | - | -543 K | -115 K | -320 K | - | -448 K | -5.24 M | 35.3 K | - | 887 K | -1.03 M | 2.58 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-36.6 M | -34.1 M | - | -27.3 M | -23.7 M | -20.5 M | - | -16.2 M | -17.6 M | -16.2 M | - | -13.4 M | -15.5 M | -14.2 M | - | -9.84 M | -10.6 M | -10.9 M | - | -7.44 M | -9.57 M | -6.81 M | - | -7.39 M | -6.92 M | -4.8 M | - | -4.69 M | -4.98 M | -4.97 M | - | -3.26 M | -3.58 M | -3.27 M | - | -4.29 M | -2.63 M | -461 K | - | -1.15 M | -21.8 M | -210 K | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
36.6 M | 34.1 M | - | 27.3 M | 23.7 M | 20.5 M | - | 16.2 M | 17.6 M | 16.2 M | - | 13.4 M | 15.5 M | 14.2 M | - | 9.84 M | 10.6 M | 10.9 M | - | 7.44 M | 9.57 M | 6.81 M | - | 7.39 M | 6.92 M | 4.8 M | - | 4.69 M | 4.98 M | 4.97 M | - | 3.26 M | 3.58 M | 3.27 M | - | 4.29 M | 2.63 M | 461 K | - | 1.15 M | 21.8 M | 210 K | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
13.8 M | 10.3 M | - | 8.89 M | 9.82 M | 9.53 M | - | 4.24 M | 4.09 M | 3.69 M | - | 2.61 M | 2.74 M | 2.69 M | - | 2.73 M | 2.83 M | 2.96 M | - | 2.16 M | 2.24 M | 2.31 M | - | 1.71 M | 1.7 M | 1.76 M | - | 1.23 M | 1.27 M | 1.44 M | - | 1.16 M | 1.21 M | 1.39 M | - | 1.78 M | 1.53 M | 322 K | - | 360 K | 514 K | 160 K | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung